Biomarker Discovery & Development | Whitepapers & Reports
Gryolab - Selective and Robust Biomarker Quantification
The use of biomarkers in biotherapeutic development to monitor drug pharmacodynamics, safety, and efficacy has been steadily increasing in an FDA-supported effort to guide decision making and improve the success of new therapeutics in clinical studies.
Related Resources
